RNPGX
Price
$71.83
Change
-$2.67 (-3.58%)
Updated
Feb 3 closing price
Net Assets
162.72B
SCMGX
Price
$21.96
Change
-$12.50 (-36.27%)
Updated
Feb 3 closing price
Net Assets
825.96M
Interact to see
Advertisement

RNPGX vs SCMGX

Header iconRNPGX vs SCMGX Comparison
Open Charts RNPGX vs SCMGXBanner chart's image
American Funds New Perspective R6
Price$71.83
Change-$2.67 (-3.58%)
VolumeN/A
Net Assets162.72B
Sands Capital Global Growth Inst
Price$21.96
Change-$12.50 (-36.27%)
VolumeN/A
Net Assets825.96M
RNPGX vs SCMGX Comparison Chart in %
View a ticker or compare two or three
VS
RNPGX vs. SCMGX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPGX is a Hold and SCMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPGX has more cash in the bank: 163B vs. SCMGX (826M). RNPGX pays higher dividends than SCMGX: RNPGX (1.28) vs SCMGX (0.07). RNPGX was incepted earlier than SCMGX: RNPGX (17 years) vs SCMGX (16 years). SCMGX (0.96) is less costly to investors than RNPGX (0.40). SCMGX is a more actively managed with annual turnover of: 37.00 vs. RNPGX (23.00). RNPGX has a lower initial minimum investment than SCMGX: RNPGX (250) vs SCMGX (1000000). RNPGX annual gain was more profitable for investors over the last year : 13.37 vs. SCMGX (-31.54). RNPGX return over 5 years is better than : 18.41 vs. SCMGX (-47.06).
RNPGXSCMGXRNPGX / SCMGX
Total Expense Ratio0.400.9642%
Annual Report Gross Expense Ratio0.400.9642%
Fund Existence17 years16 years-
Gain YTD1.641-5.263-31%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets163B826M19,734%
Annual Yield % from dividends1.280.071,838%
Returns for 1 year13.37-31.54-42%
Returns for 3 years43.00-13.90-309%
Returns for 5 years18.41-47.06-39%
Returns for 10 years131.9842.86308%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMMX6.360.15
+2.42%
Immix Biopharma
GLP47.541.00
+2.15%
Global Partners LP
EICA24.860.03
+0.14%
Eagle Point Income Company
CADE42.11N/A
N/A
Cadence Bank
PSTV0.24N/A
-0.62%
Plus Therapeutics